Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter

• Published in: Retrovirology Vol. 8; no. 1; p. 73
• Main Authors: van der Sluis, Renée M, Pollakis, Georgios, van Gerven, Marja L, Berkhout, Ben, Jeeninga, Rienk E
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16.09.2011; BioMed Central; BMC
• Subjects: Acquired immune deficiency syndrome; AIDS; Base Sequence; Binding sites; Binding sites (Biochemistry); Cell Line; Cloning; Gene expression; Gene Expression Regulation, Viral; HIV Infections - virology; HIV Long Terminal Repeat; HIV-1 - classification; HIV-1 - genetics; HIV-1 - physiology; Humans; Immune system; Molecular Sequence Data; Physiological aspects; Promoter Regions, Genetic; Promoters (Genetics); RNA polymerase; Species Specificity; Transcription factors; Virus Latency; Virus Replication; Netherlands
• ISSN: 1742-4690; 1742-4690
• DOI: 10.1186/1742-4690-8-73

HIV-1 transcription initiation depends on cellular transcription factors that bind to promoter sequences in the Long Terminal Repeat (LTR). Each HIV-1 subtype has a specific LTR promoter configuration and even minor sequence changes in the transcription factor binding sites (TFBS) or their arrangement can impact transcriptional activity. Most latency studies have focused on HIV-1 subtype B strains, and the degree to which LTR promoter variation contributes to differences in proviral latency is therefore largely unknown. Latency differences may influence establishment and size of viral reservoirs as well as the possibility to clear the virus by therapeutic intervention. We investigated the proviral transcriptional latency properties of different HIV-1 subtypes as their LTRs have unique assemblies of transcription factor binding sites. We constructed recombinant viral genomes with the subtype-specific promoters inserted in the common backbone of the subtype B LAI isolate. The recombinant viruses are isogenic, except for the core promoter region that encodes all major TFBS, including NFκB and Sp1 sites. We developed and optimized an assay to investigate HIV-1 proviral latency in T cell lines. Our data show that the majority of HIV-1 infected T cells only start viral gene expression after TNFα activation. There were no gross differences among the subtypes, both in the initial latency level and the activation response, except for subtype AE that combines an increased level of basal transcription with a reduced TNFα response. This subtype AE property is related to the presence of a GABP instead of NFκB binding site in the LTR.